J Matthes1, F Mathen, S Herzig, K Wassermann. Show Affiliations » 1. Institut für Pharmakologie der Universität zu Köln.
Abstract
Entities: Chemical Disease
Mesh: See more » Antihypertensive Agents/adverse effectsAntihypertensive Agents/economicsAntihypertensive Agents/therapeutic useEpoprostenol/adverse effectsEpoprostenol/economicsEpoprostenol/therapeutic useHemodynamics/drug effectsHypertension, Pulmonary/drug therapyIloprost/adverse effectsIloprost/economicsIloprost/therapeutic usePrognosisVasodilator Agents/adverse effectsVasodilator Agents/economicsVasodilator Agents/therapeutic use
Substances: See more » Antihypertensive AgentsVasodilator AgentsEpoprostenolIloprost
Year: 2001 PMID: 11413752 DOI: 10.1055/s-2001-14422
Source DB: PubMed Journal: Dtsch Med Wochenschr ISSN: 0012-0472 Impact factor: 0.628